The Pool for Open Innovation against Neglected Tropical Diseases (the Pool) is a consortium whose members make information and knowledge available to the public for the sole purpose of developing patents, tools, and other intellectual property to combat neglected tropical diseases. The Pool was established in February 2009 by GlaxoSmithKline and Alnylam Pharmaceuticals, and has since been joined by the Massachusetts Institute of Technology (MIT). The Pool is administered by BIO Ventures for Global Health (BVGH).
Today, Medicines for Malaria Venture (MMV) has become a contributor to the Pool, acting as the first product development partnership (PDP) in the Pool’s history. Read more about the partnership and what it means in the fight against neglected tropical diseases.
